Zdrowie i gospodarka · 17/09/2024
FDA Classifies Quantitative Viral Nucleic Acid Test for Transplant Patient Management into Class II Special Controls
The FDA has classified the quantitative viral nucleic acid test for transplant patient management into Class II special controls, aiming to ensure the device's safety and effectiveness while enhancing patients' access to innovative devices.
Source: Federal Register — Food and Drug AdministrationOpen original release →